Brief: Appili Therapeutics Presents Update On ATI-1701 Biodefense Vaccine Candidate At IDWeek™ 2024
17/10/2024 13:21
Oct 17 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS PRESENTS UPDATE ON ATI-1701 BIODEFENSE
VACCINE CANDIDATE AT IDWEEK™ 2024
Source text for Eikon: ID:nGNXb6kmSy
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez